US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Respiratory SARS-CoV-2 RT-PCR Panel 1, 384 rxns
Respiratory SARS-CoV-2 RT-PCR Panel 1, 384 rxns
Shipping box for Revvity reagent kits
EUA authorization for the simultaneous detection of SARS-CoV-2, influenza A, Influenza B, and RSV viruses.
The FDA EUA authorized Respiratory SARS-CoV-2 RT-PCR Panel 1 is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) from nasopharyngeal swabs, anterior nasal swabs, and mid-turbinate swabs, collected from individuals suspected by a healthcare provider of having respiratory viral infection consistent with COVID-19. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.
For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
EUA authorization for the simultaneous detection of SARS-CoV-2, influenza A, Influenza B, and RSV viruses.
The FDA EUA authorized Respiratory SARS-CoV-2 RT-PCR Panel 1 is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) from nasopharyngeal swabs, anterior nasal swabs, and mid-turbinate swabs, collected from individuals suspected by a healthcare provider of having respiratory viral infection consistent with COVID-19. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.
For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Respiratory SARS-CoV-2 RT-PCR Panel 1, 384 rxns
Shipping box for Revvity reagent kits
Respiratory SARS-CoV-2 RT-PCR Panel 1, 384 rxns
Product information
Overview
Conserve time and reagents while delivering relevant, accurate, and actionable results
As described in the kit insert, this RT-PCR assay targets two specific genomic regions of SARS-CoV-2: the nucleocapsid (N) gene and ORF1ab. Thus, mutations in spike protein, as seen in many Variants of Concern, do not significantly impact the safety or effectiveness of our assays.
- Efficient Processing: Resource conservation by allowing simultaneous detection of SARS-CoV-2, influenza A, influenza B, and RSV
- Scalable Workflows: Allow laboratories to scale their testing up or down
Respiratory SARS-CoV-2 RT-PCR panel 1 primers and controls
The oligonucleotide primers and probes for detection of SARS-CoV-2 were selected from the regions of the virus nucleocapsid (N) gene and ORF1ab gene. The primers and probes for detection of influenza A and RSV were selected from the regions of matrix protein. The primers and probes for detection of influenza B were selected from the regions of nuclear export protein (NEP) and nonstructural protein 1 (NS1) genes. An additional primer/probe set to detect the endogenous control gene RNase P is also included in the test. It is used for monitoring human biological material and extraction efficiency.
Probes for the amplicons of SARS-CoV-2, Influenza A, Influenza B, RSV and RNase P are labeled with FAM, ROX, Cy5, Cy5.5 and HEX/VIC fluorescent dyes respectively to generate target-specific signals.
The assay also uses a dUTP/UNG carryover prevention system to avoid contamination of PCR products and subsequent false positive results. Additionally, this kit includes positive, negative, and internal controls to prevent the reporting of incorrect results.
Rapid, high quality RNA extraction of viral RNA for respiratory RT-PCR testing
The chemagic™ Viral DNA/ RNA 300 kit H96 and chemagic 360 instrument deliver fast, high quality RNA extraction from nasopharyngeal, anterior nasal swabs, and mid-turbinate swabs. The samples can be used to prepare specimens for use with the Respiratory SARS-CoV-2 RT-PCR Panel 1.
Specifications
| Shipping Conditions |
Shipped in Dry Ice
|
|---|---|
| Unit Size |
384 rxns
|
References
Resources
Are you looking for resources, click on the resource type to explore further.
How can we help you?
We are here to answer your questions.
